EDF Health

A path to leadership: Food packaging product stewardship considerations released

Tom Neltner, J.D.is Chemicals Policy Director and Maricel Maffini, Ph.D., Consultant

Last week, we spent two days at a Chemical Watch food packaging conference with manufacturers and suppliers trying to better understand the process for bringing innovative products to market. They learned what the Food and Drug Administration (FDA) and other countries will demand and what challenges they need to anticipate. While regulatory aspects are complicated, the attendees often talked about the difficulties of navigating requirements from companies and reacting to consumer expectations about packaging chemicals.

These concerns were timely. On March 9, the Food Safety Alliance for Packaging (FSAP), a part of the Institute of Packaging Professionals, released “Food Packaging Product Stewardship Considerations,” a set of best practices. This marks the first public recognition by a sector of the packaging industry of the expectations and demands from food manufacturers, retailers, and consumers.

Read More »

Posted in FDA, Food, Regulation / Tagged , , , , | Read 1 Response

Too little, too fast: EDF comments raise numerous concerns with EPA’s proposal to expand use of a toxic chemical

Richard Denison, Ph.D., is a Lead Senior Scientist.

Last month EDF blogged about  our request to the Environmental Protection Agency (EPA) to extend the illegally and unreasonably short 15-day comment period it had provided on a modification EPA is proposing to make to expand the ways a toxic chemical could be used, subject to certain conditions, without triggering any requirement to first notify EPA.  Specifically, EPA is proposing to modify the Significant New Use Rule (SNUR) applicable to the chemical – which currently limits its use to metalworking fluid – to allow the chemical also to be used as an anti-corrosive agent in in oilfield operations and hydraulic fluids.

Our request  also noted that EPA had failed to provide the public with anything approaching a complete set of documents relevant to its proposal.  For example, the public docket for the proposed modified SNUR lacked even a redacted copy of the Significant New Use Notice (SNUN) that triggered EPA’s consideration of the expanded use.

EPA’s proposal to amend the SNUR noted that, while EPA was expanding the allowable uses of the chemical, it was also proposing to impose additional conditions on the use.  These conditions were necessary, EPA argued, because of “test data on the substance and on new data regarding the expected release of formaldehyde from the substance, for skin and eye irritation, neurotoxicity, mutagenicity, oncogenicity, allergic responses, and developmental toxicity.”

Yet the docket did not include copies of these health and safety studies or the test data, despite being referred to in the proposal and in other documents that are in the docket.  As a reminder, such health and safety studies and their underlying data must be made public under the Toxic Substances Control Act (TSCA).  And of course, access to them is crucial if the public is expected to comment on EPA’s proposal.

A few days before the end of the 15-day comment period, EPA did grant a 17-day extension.  It also added a copy of the SNUN to the docket.  But it failed to add any of the health and safety studies or associated data we had identified as missing.

The comment period ended yesterday, and despite the serious time constraint and information gaps, EDF filed these extensive comments last night.  In preparing our comments, however, we found that the amount of health and safety data EPA had failed to provide is even greater than we had originally thought.  And our concerns over the adequacy of EPA’s review of this new proposed use and of the conditions it proposes to include in the modified SNUR have only grown.   Read More »

Posted in Health policy, TSCA reform / Tagged , , | Comments are closed

Washington State takes action to eliminate use of PFAS in food packaging

Tom Neltner, J.D.is Chemicals Policy Director and Maricel Maffini, Ph.D., Consultant

Around 1990, driven by a concern to keep heavy metals out of recycled products, many states adopted laws prohibiting the intentional addition of arsenic, cadmium, lead, and mercury to packaging and limited their total concentration to 100 parts per million. Manufacturers and suppliers of packaging and packaging components in these states were also both required to furnish a Certificate of Compliance to the packaging purchaser and provide a copy to the state and the public upon request. The Toxics in Packaging Clearinghouse currently reports that 19 states have adopted this type of legislation.

Out of concern about consumer’s health and contamination of compost, on February 28, 2018, Washington State extended its heavy metal packaging law in a groundbreaking way. The legislature passed HB-2658 banning the intentional use of “perfluoroalkyl and polyfluoroalkyl substances” (PFAS) in food packaging made from plant fibers, pending a determination by the Washington Department of Ecology that safer alternatives are available. The law defines PFAS as “a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.”

The ban goes into effect in 2022 or two years after the Department makes the safer alternative determination, whichever is later.[1] If, after evaluating the chemical hazards, exposure, performance, cost, and availability of alternatives, the Department does not find safer alternatives by 2020, it must update its analysis annually. We anticipate that this approach will spur innovation among companies offering alternatives and provide a thoughtful and rigorous review of the options.

Read More »

Posted in FDA, Food, Health policy, Health science, Public health / Tagged , , , , , | Comments are closed

ACC’s state of denial about the Lautenberg Act widens – and has further infected EPA, now in its fee rule

Richard Denison, Ph.D., is a Lead Senior Scientist.

I was on vacation last week, so I missed two notable pronouncements from the American Chemistry Council (ACC) regarding the 2016 reforms to the Toxic Substances Control Act (TSCA) and implementation of them by the Environmental Protection Agency (EPA).

One was a statement issued by ACC upon publication of EPA’s proposed “TSCA fee rule” in the Federal Register on February 27.  The other was remarks given by Cal Dooley, ACC’s CEO and President, to kick off the chemical industry annual GlobalChem meeting on March 1.  Let me start with the fee rule.   Read More »

Posted in Health policy, Industry influence, TSCA reform / Tagged , | Comments are closed

EDF files Opening Brief in legal challenge to EPA’s Inventory Notification Rule

Late yesterday, EDF filed our Opening Brief in our case challenging EPA’s Inventory Notification Rule.  The Brief was filed with the U.S. Court of Appeals for the District of Columbia Circuit.

Our Brief argues in favor of the public’s right to know.  Among other arguments, it explains that EPA erred by allowing companies to assert “Confidential Business Information” (CBI) claims that do not meet the law’s requirements.  As a result, EPA will be concealing information about chemicals, particularly information about specific chemical identities, in violation of the public’s right to know.  EDF also filed our two-volume Addendum supporting EDF’s standing to pursue this lawsuit.  The Addendum proves that EDF uses this kind of information to study and communicate to the public about chemicals and to advocate for measures to protect public health.

EPA’s response brief in the case is due to the Court on May 21, 2018.

 

Posted in Health policy, TSCA reform / Tagged , , | Comments are closed

The Big Squeeze: Dangers for public health lurk in recent EPA re-org efforts

Jennifer McPartland, Ph.D., is a Senior Scientist with the Health Program.

Over the past several months, the Environmental Protection Agency (EPA) has made or proposed a number of distressing shifts in offices or staff that support critical chemicals-related activities and scientific research. The programs affected include the Integrated Risk Information System (IRIS) program, the Safer Choice program, and the National Center for Environmental Research (NCER). Not coincidentally, each of these programs has been in the crosshairs of certain segments of industry and its allies in Congress and the Administration.

This blog post briefly reviews the proposed or implemented shifts and their implications.   Read More »

Posted in Health policy, Health science, Industry influence / Tagged , | Comments are closed